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1. Introduction  
Deep vein thrombosis is often regarded as a disease limited of the veins of the lower 
extremities, which may sometimes – in more severe cases - extend to the pelvic veins. 
Although this holds true for over 90% of all thromboses, clinically relevant thromboses may 
be found in virtually every vein system of the body. Of these uncommon localisations of 
thromboses, deep vein thrombosis of the arms is one of the most frequent entities, 
accounting for about 5% of all thromboses (Munoz et al., 2008; Isma et al., 2010). Most cases 
of deep arm vein thrombosis develop secondary in patients with indwelling central venous 
catheters, pacemakers, malignant disease, or after surgery. Conversely, primary upper 
extremity deep venous thrombosis is observed in patients after strenuous arm exercise 
(“thrombosis par effort”), in thoracic outlet syndrome and inherited or acquired 
thrombophilia (Bernardi et al., 2006). Acute and long-time complications of upper extremity 
thrombosis may be significant and include pulmonary embolism, post-thrombotic 
syndrome and recurrent thromboembolism. In this chapter, the clinical presentation, 
diagnostic procedures, treatment and prevention of thromboses of the upper extremity will 
be reviewed. It is not unusual to find thromboses of proximal arm veins and deep veins of 
the neck region at the same time. Therefore, thromboses of the internal jugular vein, which 
are also most often observed in the presence of indwelling central venous catheters, will also 
be discussed. In this review, special emphasis will be given to the practical aspects of the 
disease, like risk factors, clinical presentation, diagnosis, and treatment of arm vein 
thrombosis. For a detailed, comprehensive overview of pathophysiological mechanisms, the 
reader will be referred to other, excellent reviews within this field. 
2. Epidemiology 
The frequency of deep arm vein thrombosis relative to all deep thromboses has been 
reported to be between 1 and 14% (Hill & Berry, 1990; Joffe et al., 2004; Spencer et al., 
2007). Recently, the prospective RIETE registry and the population based Malmö 
thrombophilia study reported both very similar rates of upper extremity deep vein 
thrombosis (4.4% and 5% of all thrombosis, respectively (Munoz et al., 2008; Isma et al., 
2010). Therefore, it can be assumed that about 5% of all thrombosis will involve the deep 
arm veins, which corresponds to an annual incidence of approximately 3 per 100.000 
patients per year (Bernardi et al., 2006). Less than 50% of these arm vein thromboses can 
be expected to extend into the internal jugular vein (Gbaguidi et al., 2011). About one 
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third of patients with deep arm vein thrombosis will have primary thrombosis, i.e. 
idiopathic and effort-related thrombosis (Paget-von Schroetter syndrome). The remaining 
two thirds of patients will have secondary upper extremity thrombosis with exogenous 
(e.g. central venous catheters) or endogenous (e.g. cancer) risk factors. In intensive care 
patients as well as in patients suffering from malignant disease with central venous 
catheters, rates of asymptomatic thrombosis as high as 30% to over 60% have been 
reported (Timsit et al., 1998; Van Rooden et al., 2005). There appears to be an increase in 
upper extremity deep vein thrombosis in the last decades, which may reflect the 
increasing use of central venous catheters (S. Mustafa et al., 2003; Czihal & Hoffmann, 
2011), improved diagnostic methods, or both. 
3. Anatomy of the deep arm veins 
The anatomy of the deep veins of the upper extremity is shown schematically in Figure 1. 
The two brachiocephalic veins (also known as innominate veins) join to form the superior 
vena cava. Each brachiocephalic vein is formed by the confluence of the subclavian with the 
internal jugular vein. The subclavian vein arises from (usually more than one) axillary veins, 
which originate from the usually paired brachial veins. The main superficial arm veins, the 
cephalic and basilic veins, usually drain into the sublcavian and axillary vein, respectively. 
The other, smaller arm veins (radial and ulnar veins) are only rarely involved in clinically 
significant deep vein thrombosis. Superficial thrombophlebitis may involve the cephalic and 
basilic veins as well as the smaller superficial veins in the cubital region or forearm. Of note, 
the subclavian vein passes between the clavicle and the first rib ventral of the anterior 
scalenus muscle, where it may be compressed in some patients especially during strenuous 
arm exercise. In some patients, this space is further limited by muscular hypertophy 
(anterior scalenus or suclavius muscle) or bone abnormalities (clavicle, first rib, cervical rib), 
resulting in venous thoracic outlet syndrome (Illig & Doyle, 2010). 
Internal jugular vein
Subclavian vein
Brachial vein
Superior vena cava
Cephalic vein
Brachiocephalic vein
Axillar vein
 
Fig. 1. Schematic view of the principal neck and arm veins. 
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4. Risk factors for arm vein thrombosis 
Compared to deep vein thrombosis of the legs, local factors play a dominant role in deep 
arm vein thrombosis. By far the highest risk for thrombosis in this region is caused by 
foreign material in the lumen of the arm veins, most importantly indwelling central venous 
catheters and pacemaker leads. The odds ratio for arm vein thrombosis of patients carrying 
these intravascular devices compared to patients that do not has been reported to be as high 
as 10 to more than 1000 (Joffe et al., 2004; Blom et al., 2005), Table 1. This large variation in 
risk may in part be explained by specific features of the central venous catheter, as e.g. 
catheter type and material, site, technique and level of insertion as reviewed by Van Rooden 
et al., 2005. Additional factors that have an impact on the risk of thrombosis in patients with 
central venous catheters include the number of punctures during catheter insertion, the 
duration of catheterization, the fluid administered, and catheter related infections (Koksoy 
et al., 1995; Hernandez et al., 1998; Martin et al., 1999). In addition, wrong placement of the 
catheter tip in the upper half of the superior vena cava, subclavian or innominate veins 
results in a higher risk of thrombosis (Luciani et al., 2001; Verso et al., 2008). Implanted port 
a cath systems and pacemaker leads significantly increase the risk of arm vein thrombosis as 
well (Van Rooden et al., 2004; Goltz et al., 2010). The major pathogenetic mechanism appears 
to be the thrombogenicity of the foreign material itself. Other possible factors include injury 
of the vascular wall and disturbances of venous blood flow (Beathard, 2001). Different types 
of thrombi associated with central venous catheters have been described, ranging from 
fibrin sleeves that may be embolized following catheter removal, nonocclusive mural 
thrombi and complete venous obstruction (Brismar et al., 1981; Martin et al. 1999; Beathard, 
2001). The second major risk factor for arm vein thrombosis is the presence of active 
malignant disease. Since chemotherapeutic agents are frequently delivered via central 
venous catheters, both major risk factors are often present in cancer patients. However, 
malignant disease carries a significant risk also in the absence of foreign material in the arm 
veins. The mechanisms by which malignant tumors promote thrombosis in various venous 
segments include local arrosion or invasion of blood vessels, hypercoagubility of the blood 
by the expression of tumor antigens, and stasis by tumor compression of venous segments 
proximal to the site of thrombosis (Sood, 2009; Martinelli et al., 2010). It is the experience of 
clinicians treating patients with thrombosis that this disease is most aggressive and difficult 
to treat in tumor patients. Hospitalisation has also been cited as a strong risk factor, which 
may be explained by the increasing frequency of complex therapeutic regimens requiring 
central venous lines for various indications (Joffe et al., 2004; Mai & Hunt, 2011). Other 
major risk factors are listed in Table 1 and include local factors (arm surgery, arm injury and 
immobilisation of the upper extremities by plaster casts), unusual strenuous arm exercise 
(“thrombosis par effort”), a family history of venous thromboembolism and inherited forms 
of thrombophilia, and the use of estrogen containing contraceptive drugs (Martinelli et al., 
2004; Joffe et al., 2004; Blom et al., 2005). Although cited frequently, a thoracic outlet 
syndrome is diagnosed in comparably few cases (Blom et al., 2005). Several unusual risk 
factors for arm vein thrombosis have been reported in case reports, including backpacking 
(Schoen et al., 2007), portable computer games (Phipps & Joo, 2008), ambulatory blood 
pressure monitoring (Marschang et al., 2008), intravenous calcium guconate injection (Chen 
et al., 2009), and infraclaviculary lipoma (Palamari et al., 2010). Interestingly, two known 
risk factors for lower extremity deep vein thrombosis, namely age and obesity, do not 
appear to confer additional risk for upper deep vein thrombosis (Joffe et al., 2004; Mai & Hunt, 
2011). Isolated thrombosis of the internal jugular vein may be observed in the context of two 
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distinct clinical entities, namely after recent oropharyngeal infections with anaerobic bacteria 
(fusobacterium necrophorum) and in the ovarian hyperstimulation syndrome (Gbaguidi et al., 
2011). For the latter syndrome, the increased risk of thrombosis has been explained by the 
drainage of excessive estrogen concentrations in the peritoneal fluid via the thoracic and right 
lymphatic duct into the confluence region of the large neck veins (Bauersachs et al., 2007).  
Risk factor 
Odds 
ratio 
95 % Confidence 
interval 
Reference 
Central venous catheter
1136 153 - 8448 Blom et al. 2005 
9.7 7.8 – 12.2 Joffe et al. 2004 
Active cancer 18.1 9.4 – 35.1 Blom et al. 2005 
Arm surgery 13.1 2.1 – 80.6 Blom et al. 2005 
Plaster cast 7.0 1.7 – 29.5 Blom et al. 2005 
Factor V Leiden* 6.2 2.5 – 15.7 Martinelli et al. 2004 
Prothrombin G20210A* 5.0 2.0 – 12.2 Martinelli et al. 2004 
Protein C, Protein S 4.9 1.1 – 22.0 Martinelli et al. 2004 
Family history of VTE 2.8 1.6 – 4.9 Blom et al. 2005 
Arm injury 2.1 0.7 – 6.2 Blom et al. 2005 
Oral contraceptives 2.0 1.1 -3.8 Blom et al. 2005 
Unusual arm exercise 1.5 1.0 – 2.1 Blom et al. 2005 
*heterozygous mutation. VTE venous thromboembolism 
Table 1. Major risk factors for arm vein thrombosis with odds ratios adjusted for age and sex.  
5. Clinical presentation 
The presence of typical symptoms (swelling of the upper extremity, localized pain, and 
superficial collaterals) will raise the suspicion of the clinician to consider deep vein 
thrombosis of the arms. The most frequent symptom is edema of the upper extremity, which 
has been reported in 80% of cases by Joffe and coworkers . In addition, about 40% of patients 
report localized pain or aching discomfort in the involved extremity (Joffe et al., 2004). Other 
symptoms include reddish-blue discoloration, a sensation of heat or heaviness in the 
respective arm, or dilated superficial collateral veins on the upper arm, shoulder girdle, 
neck, and anterior chest wall (Prandoni et al., 1997a; Kommareddy et al., 2002; Bernardi et 
al., 2006). In at least 5% of cases, deep vein thrombosis of the arms will be completely 
asymptomatic (Mai & Hunt, 2011). In some cases, patients will become symptomatic only 
after the occurrence of complications, like dyspnea in the case of pulmonary embolism, or 
rarely venous gangrene (Kaufman et al., 1998). In dialysis patients, arm vein thrombosis 
may become symptomatic only by catheter dysfunction, like the inability to draw blood, 
increased dialysis pressure or arm swelling after dialysis (Hernandez et al., 1998). 
In addition, classical syndromes have been described which share some but not all of their 
symptoms with the clinical picture described above. Superior vena cava syndrome has been 
described as a complication especially of catheter related arm vein thrombosis, but may also 
be caused by other mechanisms, e.g. venous compression by chest tumors (Lepper et al., 
2011). It comprises usually bilateral edema of the face, neck, and upper extremities, together 
with cyanosis, plethora, and dilated subcutaneous vessels. Paget von Schroetter´s syndrome, 
which was first described at the end of the 19th century, is defined as a primary thrombosis 
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of the subclavian vein at the costoclavicular junction. This syndrome is usually precipitated 
by musculoskeletal compression and / or repetitive microtrauma by strenuous arm exercise 
(thrombosis par effort) (Constans et al., 2008; Illig & Doyle, 2010). In some cases, a 
compression of the subclavian vein by muscular hypertophy (anterior scalenus muscle, 
subclavian muscle) or by the clavicle and the first rib with extreme arm movements 
(hyperabduction and elevation) may be responsible (thoracic outlet syndrome). Likewise, 
the syndrome has been linked to certain sport activities, as e.g. weight lifters, baseball 
pitchers or tennis players (Sheeran et al., 1997; van Stralen et al., 2005). It is observed more 
frequently in young patients, men (2:1), and in the dominant extremity (Illig & Doyle, 2010). 
The typical clinical presentation of this syndrome is a sudden onset of the typical symptoms 
of deep vein thrombosis described above (Illig & Doyle, 2010). Isolated thrombosis of the 
internal jugular vein is a rare disease which may be due to local (central venous catheters, 
recent oropharyngeal infections with anaerobic bacteria like fusobacterium necrophorum) or 
systemic factors (cancer, thrombophilia, ovarian hyperstimulation syndrome) (Sheikh et al., 
2002; Gbaguidi et al., 2011). Lemierre´s syndrome, first described in 1910, is a severe 
condition of septic thrombosis following oropharyngeal infections, mostly due to 
fuosbacterium necrophorum. This syndrome is also known as human necrobacillosis or 
post-anginal septicaemia. Besides local symptoms (cervical edema, localized pain, dilated 
superficial collateral veins, erythrocyanosis, indurated vein), severe systemic complications 
like septicaemia and septic pulmonary embolism may occur (Vargiami & Zafeiriou, 2010; 
Gbaguidi et al., 2011). 
When evaluating patients for clinical signs of deep arm vein thrombosis, it is important to 
bear in mind possible alternative diagnoses. These include e.g. superficial thrombophebitis, 
paravasates after peripheral infusions, lymphedema, cellulitis, haematoma, venous 
compression and traumatic injuries (Kommareddy et al., 2002; Bernardi et al., 2006). 
6. Diagnostic procedures 
As in thrombosis of the lower extremities, there are no reliable clinical symptoms to 
diagnose deep arm vein thrombosis. Therefore, diagnostic test are necessary to diagnose or 
rule out upper extremity thrombosis. Contrast venography is the gold standard diagnostic 
method, allowing an unparalleled overview of all arm veins with high resolution (Fig 2). 
However, venography is invasive, inconvenient for the patient and suffers from moderate 
inter-observer agreement rates (between 71 and 83%) in upper extremity deep vein 
thrombosis (Baarslag et al., 2003). Furthermore, possible complications as contrast agent 
mediated kidney damage, allergic reactions and even venography-induced thrombosis can 
occur (Bernardi et al., 2006). 
Ultrasound has several advantages compared to invasive methods and has become the 
diagnostic method of choice in lower extremity deep vein thrombosis (Kearon et al., 1998; 
Goodacre et al., 2006). The main strengths of ultrasound are its non-invasive nature, general 
availability, as well as the lack of radiation and contrast material. However, ultrasound 
suffers generally from some disadvantages, including observer variability and usually lack 
of standardized documentation. In arm vein thrombosis, an additional obstacle is the 
portion of the subclavian vein behind the clavicle, impeding compression manoeuvres in 
this clinically important region. In addition, the brachiocephalic veins and the superior vena 
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cava cannot be examined directly. In a substantial number of cases it will therefore be 
necessary to rely on indirect signs, as e.g. lack of Doppler signals (Fig. 3B) or characteristic 
changes in the Doppler flow distal of the occluded segment (Fig. 4). Nevertheless, several 
studies have shown high sensitivity and specificity of different ultrasound modalities 
(continuous wave ultrasound, compression ultrasound, colour Doppler ultrasound) in 
patients with suspected arm vein thrombosis (Prandoni et al., 1997a; B. O. Mustafa et al., 
2002; Di Nisio et al., 2010); see Table 2. Despite these impressive numbers, the clinician 
should bear in mind that all these studies of arm vein thrombosis have been performed in 
relatively few patients. Therefore, the reported confidence intervals are wide and the safety 
of withholding therapy in a patient with negative ultrasound has not been proven 
prospectively in an adequately powered study (B.O. Mustafa et al. 2002). Even with these 
limitations, ultrasound is a valuable tool for the diagnosis of deep arm vein thrombosis in 
the hand of an experienced operator, and should be performed in most cases as the first 
imaging test. For magnetic resonance imaging, a study with 44 patients comparing time of 
flight and Gadolinium-enhanced imaging reported a moderate sensitivity and specificity 
(Baarslag et al., 2004). Computed tomography scanning for the diagnosis of deep arm vein 
thrombosis has only been described in a small case series (Kim et al., 2003), although this 
modality is often used to detect thrombi in clinical practice (Fig. 3A). 
  
Fig. 2. Venogram of a chronic occlusion of the left subclavian vein with extensive 
collateralization (Department of Radiology, Innsbruck Medical University). 
Since there is no imaging method combining optimal accuracy and minimal burden for the 
patient, alternative methods have been searched for. An interesting clinical prediction score 
for arm vein thrombosis, reminiscent of the Wells score for lower extremity thrombosis 
(Wells et al., 1997), has been published by Constans and coworkers (Constans et al., 2008). 
This simple score assigns one point each for a central venous catheter or pacemaker lead, 
localized pain and unilateral edema. One point is subtracted in the case that an alternative 
diagnosis would seem at least as likely as deep arm vein thrombosis. D-dimer testing has 
also been evaluated in a cohort of patients with suspected deep arm vein thrombosis 
(Merminod et al., 2006). Although nearly 100% sensitive, D-dimer suffers from a low 
specificity.  
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Fig. 3. Computed tomography scan (A, Department of Radiology, Innsbruck Medical 
University) and colour duplex ultrasound (B) of the same patient showing a floating 
thrombus in the left internal jugular vein. 
Test Sensitivity Specificity Advantage Disadvantage Reference 
Clinical score 78% 64% simplicity performance Constans et al. 2008 
D-Dimer 100% 14% sensitivity specficity Merminod et al. 2006 
CUS 96% 94% noninvasive
operator-
dependent 
Di Nisio et al. 2010 
CUS + CD 100% 93% noninvasive
operator-
dependent 
Di Nisio et al. 2010 
MRI 71% 89% overview cost Baarslag et al. 2004 
Venography 100% 100% overview invasive Baarslag et al. 2003 
Table 2. Strengths and weaknesses of diagnostic tests for suspected deep arm vein 
thrombosis. CUS compression ultrasound. CD colour Doppler ultrasound. MRI magnetic 
resonance imaging. 
A B
 
Fig. 4. Indirect sonographic diagnosis of a non-recent thrombosis of the left sublcavian vein 
with partial recanalisation. Normal venous flow with cardiac and respiratory modulation in 
the right subclavian vein (A) compared to linear flow in the left subclavian vein (B). 
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7. Natural history and complications 
Compared to lower extremity deep vein thrombosis, relatively little is known about the 
natural history of deep arm vein thrombosis. The follow-up of patients not receiving 
anticoagulant treatment was reviewed by Thomas & Zierler, who found high rates of post-
thrombotic syndrome (74%) and pulmonary embolism (12%) in patients treated only with 
physical methods (rest, heat, elevation) (Thomas & Zierler, 2005). These findings underscore 
the importance of a correct and fast diagnosis of upper extremity deep vein thrombosis and 
challenge the common view of arm vein thrombosis as a relatively harmless disease. However, 
even patients that are treated according to current guidelines have a significant risk of severe 
complications (Table 3). Compared to lower extremity deep vein thrombosis, patients with 
deep arm vein thrombosis present less frequently with concomitant pulmonary embolism (9% 
versus 30%) (Munoz et al., 2008; Lechner et al., 2008). However, pulmonary embolism caused 
by deep arm vein thrombosis can even be fatal in rare cases (Monreal et al., 1994). With the 
exception of patients with malignancies, the recurrence rate tends to be lower than in deep 
vein thrombosis (Spencer et al., 2007; Munoz et al., 2008). However, the total mortality of 
patients with upper extremity and lower extremity thrombosis appears to be similar and is 
mainly related to the underlying disease (Spencer et al., 2007; Munoz et al., 2008). Contrary to 
common believe, post-thrombotic syndrome is not a rare complication in deep arm vein 
thrombosis and may lead to functional disability and significant impaired quality of life in 
these patients (Prandoni et al., 2004; Kahn et al., 2005; Vik et al., 2009). Two modified versions 
of a validated score system for post-thrombotic syndrome in lower extremity thrombosis 
(Prandoni et al., 1997b) have been adapted to arm vein thrombosis (Table 4). 
Complication Frequency References
Recurrence 78 / 1060
(7.4%) 
Martinelli et al. 2004, Bernardi et al. 2006, Spencer  
et al. 2007, Munoz et al. 2008, Isma et al. 2010 
Pulmonary embolism 186 / 2094 
(8.9 %) 
Kommareddy et al 2002, Bernardi et al. 2006, 
Spencer et al. 2007, Munoz et al. 2008, Lechner et al. 
2008 
Fatal pulmonary 
embolism 
10 / 1156
(0.87%) 
Bernardi et al. 2006, Munoz et al. 2008 
Post-thrombotic 
syndrome 
141 / 610
(23%) 
Bernardi et al. 2006
Table 3. Common complications of deep arm vein thrombosis.  
8. Treatment 
Due to the lack of adequately powered, randomized clinical trials the current guidelines for 
the treatment of arm vein thrombosis are mainly based on small cohort studies, expert 
opinion or extrapolation of data derived from larger studies performed in patients with 
lower extremity deep vein thrombosis. Nevertheless, the eight edition of the American 
college of chest physicians’ (ACCP) guidelines cover several important aspects of the 
treatment of patients with upper extremity deep vein thrombosis (Kearon et al., 2008). For 
the initial treatment, therapeutic doses of low molecular weight heparin, unfractionated 
heparin or fondaparinux are recommended. Overlapping with this initial treatment, long-
term anticoagulation with a vitamin K antagonist should be started and continued for a 
minimum of 3 months. No studies are available that have addressed the ideal duration of  
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anticoagulant therapy in patients with arm vein thrombosis. There is no specific 
recommendation in the ACCP guidelines on the treatment of cancer patients with upper 
extremity deep vein thrombosis. In cancer patients with deep arm vein thrombosis, the use 
of low molecular weight heparins instead of vitamin K antagonist as long-term treatment 
has been suggested in analogy to lower extremity thrombosis, but there are currently no 
studies supporting this approach (Shivakumar et al., 2009). Although various degrees of 
post-thrombotic syndrome have to be expected in the long term follow up of about 1 in 4 
patients with upper extremity deep vein thrombosis, the ACCP guidelines do not advocate 
the routine use of elastic bandages or compression sleeves for the arm, unless patients report 
severe symptoms like persistent edema and pain.  
A number of studies have described case series of deep arm vein thrombosis treated with a 
variety of invasive therapeutic options, including catheter-guided thrombolysis, 
percutaneous angioplasty with or without venous stent insertion, surgical thrombectomy 
and surgical decompression of costoclavicular narrowing to correct thoracic inlet syndrome, 
e.g. by first rib resection (Zimmermann et al., 1981; Becker et al., 1983; Machleder, 1993; 
Urschel & Razzuk, 1998). Some investigators recommend such an invasive approach 
routinely e.g in patients with effort related thrombosis (Paget von Schroetter´s syndrome) 
(Kommareddy et al., 2002). Here, the ACCP guidelines clearly do not recommend invasive 
procedures routinely, but only in selected patients and in specially equipped centers. It 
remains to be determined in adequately designed, randomized clinical trials whether these 
invasive procedures, which carry a substantial risk of major bleeding and other serious 
complications, provide a benefit compared to standard anticoagulation with optimal 
mechanical compression using elastic bandages.  
Subjective symptoms Objective Signs Subjective symptoms Objective Signs 
Heaviness Edema Heaviness Edema 
Pain Skin induration Pain Prominent veins on arm 
Pruritus Discoloration Pruritus 
Prominent veins over 
shoulder or anterior 
chest wall 
Physical limitation Venous ectasia Cramps Dependent cyanosis 
Paraesthesia Redness Paraesthesia Redness 
 
Pain during 
compression
 Tenderness 
Prandoni et al. 2004, Vik et al. 2009 Kahn et al. 2005
Table 4. Two suggested modifications of the Villalta scale for the assessment of post-
thrombotic syndrome in deep arm vein thrombosis. Each sign or symptom is graded as 0 
(absent), 1 (mild), 2 (moderate) or 3 (severe). A score of 5 or higher is classified as post-
thrombotic syndrome and score of 15 or higher as severe post-thrombotic syndrome. 
Another point of debate is the question whether central venous catheters should be removed 
when a diagnosis of deep vein thrombosis has been confirmed in the respective vessel. Most 
experts opt against catheter removal, if the catheter is still needed and still functional. In a 
cohort study of 74 cancer patients with acute upper extremity thrombosis, the catheters were 
not removed and patients were treated for 3 months with standard anticoagulation without 
recurrent episodes of venous thromboembolism (Kovacs et al., 2007). If the catheter is 
removed, the ACCP guidelines recommend not to shorten the anticoagulation period below 
3 months (Kearon et al., 2008). 
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9. Prevention 
Patients with central venous catheters carry a high risk of deep arm vein thrombosis, which 
may exceed 60 % in certain patient groups (ICU patients, oncological and hematological 
patients) Van Rooden et al., 2005. Therefore, approaches to prevent catheter-related 
thrombosis by means of pharmacological prophylaxis e.g. in cancer patients, appear 
attractive. However, despite an early study showing benefit of low dose warfarin in this 
context (Bern et al., 1990), subsequent studies with warfarin and heparins could not confirm 
this protective effect. A recent meta-analysis did show a trend, but no significant reduction 
of symptomatic deep vein thrombosis with any form of thromboprophylaxis (Akl et al., 
2008). In accordance with these data, the current guidelines for the prevention of venous 
thromboembolism do not recommend routine use of thromboprophyaxis in cancer patients 
with indwelling central venous catheters (Geerts et al., 2008). 
The placement of superior vena cava filters has been reported in case reports and small case 
series. Although effective in preventing pulmonary embolism from thrombi in the upper 
extremities, these filters may cause severe complications, like cardiac tamponade and aortic 
perforation (Owens et al., 2010) and do not protect from thrombi in the lower extremities. 
Therefore, the placement of these filters should be limited to special situations (Kucher, 2011). 
10. Conclusions / open questions 
About 5% of all thromboses are expected to occur in the deep veins of the upper extremities. 
Besides effort-related thromboses, most patients with arm vein thrombosis have typical risk 
factors, like central venous catheters or malignancies. Typical clinical syndromes include 
edema and localized pain, whereas other patients are asymptomatic or present with complex 
syndromes. Today, diagnosis will most often be performed by ultrasound; in some cases 
additional testing (e.g. computed tomography scanning, magnetic resonance imaging) will be 
necessary. The most important complications are recurrent thrombosis, pulmonary embolism 
and post-thrombotic syndrome. Treatment should be initiated without delay and consist in 
most cases of standard anticoagulation treatment with heparins followed by a vitamin K 
antagonist for at least 3 months. In selected cases, invasive therapeutic regimes including 
catheter-guided thrombolysis and surgical procedures may be applied. Routine prevention of 
catheter-related thrombosis or embolic complications by anticoagulants in prophylactic doses 
or implantation of superior vena cava filters is not recommended. Compared to deep vein 
thrombosis of the lower extremities, deep vein thrombosis of the arm veins has been studied 
much less intensely. For example, the optimal duration of anticoagulant therapy and the value 
of compression therapy are not precisely known for arm vein thromboses. Therefore, many of 
the current recommendation are in fact extrapolations from data on deep leg vein thrombosis. 
Specific studies are needed to better understand the pathogenesis of deep vein thrombosis of 
the arms and to improve diagnostic and therapeutic strategies.  
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